WALL STREET ASSOCIATES - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 139 filers reported holding ACCELERON PHARMA INC in Q3 2016. The put-call ratio across all filers is 1.27 and the average weighting 0.8%.

Quarter-by-quarter ownership
WALL STREET ASSOCIATES ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2016$232,000
+6.9%
6,4000.0%0.08%
-9.2%
Q2 2016$217,000
-30.4%
6,4000.0%0.09%
-1.1%
Q4 2015$312,000
-87.0%
6,400
-91.6%
0.09%
-61.2%
Q2 2015$2,405,000
-20.0%
76,000
-3.8%
0.23%
-20.1%
Q1 2015$3,007,000
-6.7%
79,000
-4.5%
0.28%
-8.1%
Q4 2014$3,222,000
+28.1%
82,700
-0.6%
0.31%
+18.8%
Q3 2014$2,516,000
-20.5%
83,200
-10.6%
0.26%
-4.4%
Q2 2014$3,163,000
-1.2%
93,100
+0.3%
0.27%
+4.2%
Q1 2014$3,202,000
-13.8%
92,800
-1.1%
0.26%
-14.4%
Q4 2013$3,714,000
+91.0%
93,800
+7.2%
0.30%
+68.5%
Q3 2013$1,945,00087,5000.18%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2016
NameSharesValueWeighting ↓
Novo Holdings A/S 1,103,937$53,563,0005.39%
GREAT POINT PARTNERS LLC 758,000$36,778,0005.10%
Foresite Capital Management II, LLC 244,756$11,876,0004.18%
GREAT POINT PARTNERS LLC 552,300$26,798,0003.71%
Foresite Capital Management III, LLC 278,753$13,525,0002.91%
QVT Financial LP 190,977$9,266,0002.66%
Perceptive Advisors 1,528,205$74,149,0001.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,800$54,672,0001.92%
SECTORAL ASSET MANAGEMENT INC 306,626$14,877,0001.66%
Parametrica Management Ltd 5,645$274,0001.30%
View complete list of ACCELERON PHARMA INC shareholders